1
Back
C

cancer immunology, immunotherapy

IF
Papers184
Citations
Journal Papers 264
Publication Date
delete
Restoring STING expression in soft tissue sarcoma increases activation and function of tumor-infiltrating lymphocytes
deletecancer immunology, immunotherapy
IF0
delete2026-06-21
delete0
deleteOAAI
deleteStine Høvring Godsk; Mireia Crus De los Santos; Tobias Wang Bjerg; Thomas Gravgaard Andersen; Felix Haglund de Flon; Maria Elisabeth Harder; Anders Etzerodt; Ninna Aggerholm-Pedersen; Andreas Lundqvist; Martin Roelsgaard Jakobsen
deleteShare
deleteSave
Smoking-associated modulation of gut microbiota shapes response to immune checkpoint inhibitors in non-small cell lung cancer
deletecancer immunology, immunotherapy
IF0
delete2026-06-21
delete0
deleteOAAI
deletePo-Yu Chien; Wen-Chien Cheng; Chin-Chuan Hung; Chih-Yen Tu; Te-Chun Hsia; Der-Yang Cho; Po-Ren Hsueh; Zi-Lun Lai; Yi-Cheng Shen; Yu-Chao Lin
deleteShare
deleteSave
Oncolytic virus with an immune stimulatory payload for osteosarcoma therapy
deletecancer immunology, immunotherapy
IF0
delete2026-06-20
delete0
deleteOAAI
deleteSumbul Khan; Theresa A. Higgins; Isabella Shimko-Lofano; Maninder Sandey; Emma Logsdon; Gracie Bunch; Yasin Fatemi; Leah M. K. Hoffman; Bruce F. Smith; Payal Agarwal
deleteShare
deleteSave
Single-cell and multi-omics integration delineates the landscape of gene-wise intratumor heterogeneity and identifies prognostic biomarkers for immunotherapy in non-small cell lung cancer
deletecancer immunology, immunotherapy
IF0
delete2026-06-20
delete0
deleteOAAI
deleteJianye Yuan; Zelin Weng; Zhenguo Li; Rui Chen; Chao Cheng; Weixiong Yang; Xiuying Xie; Chang Luo; Tao Wang; Shuishen Zhang; Zihui Tan
deleteShare
deleteSave
A phase I study evaluating subcutaneous administration of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced solid malignancies
deletecancer immunology, immunotherapy
IF0
delete2026-06-18
delete0
deleteOAAI
deletePiotr Rutkowski; Dariusz M. Kowalski; Victor Moreno; Aitana Calvo; Fiona Thistlethwaite; Ruth Plummer; Douglas Steinbach; John Loffredo; Sydney Akapeme; Daniel Jonathan; Vinod Philip; Angela Girvin; Shalaka Hampras; Peter Hellemans; Iurie Bulat
deleteShare
deleteSave
Impact of PD-1+Tim-3+CD8+ T cells in pretreatment tumors on chemotherapy responses in esophageal cancer
deletecancer immunology, immunotherapy
IF0
delete2026-06-18
delete0
deleteOAAI
deleteTomoko Sumimoto; Kei Yamamoto; Takuro Saito; Shinya Urakawa; Tomohira Takeoka; Tomoki Makino; Yukinori Kurokawa; Atsunari Kawashima; Azumi Ueyama; Hidetoshi Eguchi; Yuichiro Doki; Hisashi Wada
deleteShare
deleteSave
Bintrafusp alfa for patients with recurrent or metastatic olfactory neuroblastoma
deletecancer immunology, immunotherapy
IF0
delete2026-06-17
delete0
deleteOAAI
deleteNyall R. London; Dara Bracken-Clarke; Elisabetta Xue; Isaac Brownell; Wojciech K. Mydlarz; Evrim B. Turkbey; Lisa M. Cordes; Jennifer L. Marté; Lisa M. Rooper; Shrey B. Shah; Michell Manu; Zoukaa B. Sargi; James L. Gulley; Charalampos S. Floudas
deleteShare
deleteSave
CXCL9/SPP1-polarized tumor-associated macrophages exert dual roles in regulating anti-tumor immunity in lung adenocarcinoma
deletecancer immunology, immunotherapy
IF0
delete2026-06-16
delete0
deleteOAAI
deleteHaixiao Liu; Lingyun Wang; Changlin Li; Dongtao Li; Linghan Meng; Guangda Zheng; Juanxia Ren; Lu Shang; Yanju Bao
deleteShare
deleteSave
BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia
deletecancer immunology, immunotherapy
IF0
delete2026-06-15
delete0
deleteOAAI
deleteChiara Badami; Erna Islamagic; Linnea Blomén; Frida Svensson; Theebiga Kathirkamanathan; Kristoffer Hellstrand; Elin Bernson; Fredrik B. Thorén
deleteShare
deleteSave
Real-world outcomes of ipilimumab plus nivolumab in esophageal squamous cell carcinoma: a multi-institutional large cohort study
deletecancer immunology, immunotherapy
IF0
delete2026-06-14
delete0
deleteOAAI
deleteShuichiro Hara; Tomoki Makino; Shigeto Nakai; Kota Momose; Kotaro Yamashita; Koji Tanaka; Taro Satoh; Keijiro Sugimura; Ryohei Kawabata; Atsushi Takeno; Masaaki Motoori; Makoto Yamasaki; Hiroshi Miyata; Yutaka Kimura; Takushi Yasuda; Hidetoshi Eguchi; Yuichiro Doki
deleteShare
deleteSave
Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trial
deletecancer immunology, immunotherapy
IF0
delete2026-06-13
delete0
deleteOAAI
deletePanpan Zhang; Ming Lu; Lijie Song; Yanqiao Zhang; Zhendong Chen; Chunjiao Wu; Zhiping Li; Xing Zhang; Qian Xu; Jinghong Zhou; Haiyan Shi; Panfeng Tan; Songhua Fan; Weiguo Su; Lin Shen
deleteShare
deleteSave
Donor-specific toxicity of copanlisib identified using immune-humanized mice
deletecancer immunology, immunotherapy
IF0
delete2026-06-12
delete0
deleteOAAI
deleteRobyn E. Becker; Jenny Résiliac; Kathleen L. Gabrielson; Zhuoming Liu; Kristina E. Howard
deleteShare
deleteSave
Beyond radiation: immunological potentials of boron neutron capture therapy
deletecancer immunology, immunotherapy
IF0
delete2026-06-12
delete0
deleteOAAI
deleteMuyasha Abulimiti; Yu Sugawara; Yinuo Li; Hideyuki Sakurai; Yoshitaka Matsumoto
deleteShare
deleteSave
Neoadjuvant immunochemotherapy followed by definitive radiotherapy in locally advanced head and neck squamous cell carcinoma: two-year survival outcomes
deletecancer immunology, immunotherapy
IF0
delete2026-06-12
delete0
deleteOAAI
deleteYi Xu; Yang Meng; Lin Gui; Ye Zhang; Runye Wu; Xuesong Chen; Xiaodong Huang; Kai Wang; Yuan Qu; Yuchao Ma; Jianghu Zhang; Jingbo Wang; Junlin Yi
deleteShare
deleteSave
Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients
deletecancer immunology, immunotherapy
IF0
delete2026-06-10
delete0
deleteOAAI
deleteLingling Wang; Yasi Xu; Yanyan Zhao; Bing Xia; Lucheng Zhu
deleteShare
deleteSave
Low-dose IL-2 therapy for immune-related adverse events via Tfh/Treg balance modulation: a prospective cohort and murine model study
deletecancer immunology, immunotherapy
IF0
delete2026-06-09
delete0
deleteOAAI
deleteYifan Wang; Zhening Zhang; Yufei Li; Yongjing Cheng; Min Wang; Yudong Liu; Hao Li; Zhi Peng; Jing He
deleteShare
deleteSave
Optimizing the clinical assessment of pseudoprogression in patients with solid tumors treated with checkpoint inhibitors: a systematic literature review and meta-analysis of associated features
deletecancer immunology, immunotherapy
IF0
delete2026-06-08
delete0
deleteOAAI
deleteGeorgios Fountoukidis; Elisabet Tina; Anna Göthlin-Eremo; Gustav Ullenhag; Antonios Valachis
deleteShare
deleteSave
Immune-cold NSCLC tumors harbor tumor-associated macrophages with elevated expression of immunoglobulin genes
deletecancer immunology, immunotherapy
IF0
delete2026-06-06
delete0
deleteOAAI
deleteMarkus Haug; Henrik Sahlin Pettersen; Magne Børset; Arne Kildahl-Andersen; Sissel Gyrid Freim Wahl; Arnar Flatberg; Anders Tøndell
deleteShare
deleteSave
Explainable AI reveals squamous histology and U-shaped PD-L1 patterns as primary subgroup predictors of neoadjuvant and perioperative immunotherapy benefit in NSCLC: a machine learning analysis
deletecancer immunology, immunotherapy
IF0
delete2026-06-06
delete0
deleteOAAI
deleteFangfang Shen; Zheqing Zhu; Junge Liu; Feng Li
deleteShare
deleteSave
Pan-cancer single-cell and spatial transcriptomics analyses delineate response-associated heterogeneity and therapeutic targets of tumor-infiltrating B cells following immune checkpoint blockade
deletecancer immunology, immunotherapy
IF0
delete2026-06-05
delete0
deleteOAAI
deleteJialing Fang; Hangyu Liu; Jun Lei; Yongshun Chen; Jingjing Wang
deleteShare
deleteSave